Within the framework of its sustained, entrepreneurial, internationalisation process, Industrial Farmacéutica Cantabria (IFC) is set to arrive in China after signing strategic commercial agreement with local partners. From February 2018, IFC market the brands Endocare and Heliocare in China, with a forecasted turnover of 8 million euros in the 2018 for this market. With this […]

Sales of IFC Group in 2016 topped 126 million euros, with over 20% growth on the previous year, highlighting the excellent financial health and continued progress of the company. IFC continues to grow, invest and incorporate important projects into its business, giving added value and contributing to the diversification of the business and specialisation in […]

IFC – Industrial Farmacéutica Cantabria – takes on a new challenge with the opening of a subsidiary in Mexico as part of its strategy to intensify and boost its international presence, which already forms 65% of its turnover. IFC Manging Director, Juan Matji, announced that “the opening of IFC Mexico is a true reflection of […]

IFC has disembarked on the African continent with the intention of developing business in this growing market. The headquarters in Casablanca shall manage the portfolio of dermatological and dermocosmetic products of the Neoretin ®, Heliocare ®, Endocare ® and Cicamel ® brands. With this new creation, IFC extends its geographical limits and reinforces its presence […]